Acura Pharmaceuticals, Inc. (ACUR)

Company Overview

General Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion® (abuse deterrent) Technology and related product candidates. Product candidates developed with Aversion® Technology and containing opioid analgesic active ingredients are intended to effectively treat pain and also discourage the three most common methods of pharmaceutical product misuse and abuse including; (i) intravenous injection of dissolved tablets or capsules, (ii) nasal snorting of crushed tablets or capsules and (iii) intentional swallowing of excessive numbers of tabl...

read more

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 616 N North Court, Suite 120, Palatine, IL 60067, United States
Mailing Address: -
Phone: 847-705-7709
Fax: 847-705-5399
Website: http//www.acurapharm.com

Company Details:

Symbol: ACUR
SIC: 2834
State location: IL
Sector: -
State of Inc: NY
Employees: 15
Type: -

Key executives:

Name Age Position
Andrew D. Reddick 67 Chief Exec. Officer, Pres, Director and Member of Compensation Committee
James Emigh 63 VP of Marketing and Admin.
Peter A. Clemens 67 Chief Financial Officer, Principal Accounting Officer, Sr. VP and Sec.
Robert Seiser 56 VP, Treasurer and Corp. Controller
Ron J. Spivey Ph.D. 73 Chief Scientific Officer and Sr. VP